Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SIGLEC6 |
| Upstream (Parents) |
|---|
| (<<) RNF128 → SIGLEC6 |
| (<<) STXBP1 → SIGLEC6 |
| (<<) STK3 → SIGLEC6 |
| (<<) CHM → SIGLEC6 |
| (<<) DYNC1LI2 → SIGLEC6 |
| (<<) ZNF192 → SIGLEC6 |
| (<<) ELAVL3 → SIGLEC6 |
| (<<) BCL3 → SIGLEC6 |
| (<<) PVR → SIGLEC6 |
| Downstream (Children) |
|---|
| SIGLEC6 → GRM5 (>>) |
| SIGLEC6 → H2AFX (>>) |
| SIGLEC6 → ELAVL3 (>>) |
